Skip to content

Bone Drugs May Increase Esophageal Cancer Risk

Drugs such as Actonel, Boniva, and Fosamax may increase the risk of contracting esophageal cancer, according to a new study published today in the British Medical Journal. The bone drugs belong to a…

Drugs such as Actonel, Boniva, and Fosamax may increase the risk of contracting esophageal cancer, according to a new study published today in the British Medical Journal.  The bone drugs belong to a particular class of drugs known as bisphosphonates and have been in the news before due to adverse effects such as bone loss and jaw necrosis.  A few years ago, Fosamax lawsuits were filed due to the drug’s association with jaw necrosis.

According to WebMD, there have been 34 cases of esophageal cancer linked with bisphosphonate drugs reported to the FDA.

Joseph H. Saunders

Joseph H. Saunders

Joe's philosophy is to provide aggressive, quality representations and seek fair compensation for individuals and their families who have suffered injury, death, or sexual abuse.

All articles
Tags: Health

More in Health

See all

More from Joseph H. Saunders

See all